BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Imada H, Kato H, Yasuda S, Yamada S, Yanagi T, Hara R, Kishimoto R, Kandatsu S, Minohara S, Mizoe JE. Compensatory enlargement of the liver after treatment of hepatocellular carcinoma with carbon ion radiotherapy - relation to prognosis and liver function. Radiother Oncol. 2010;96:236-242. [PMID: 20416964 DOI: 10.1016/j.radonc.2010.03.025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Bujold A, Massey CA, Kim JJ, Brierley J, Cho C, Wong RK, Dinniwell RE, Kassam Z, Ringash J, Cummings B, Sykes J, Sherman M, Knox JJ, Dawson LA. Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma. J Clin Oncol. 2013;31:1631-1639. [PMID: 23547075 DOI: 10.1200/jco.2012.44.1659] [Cited by in Crossref: 445] [Cited by in F6Publishing: 215] [Article Influence: 49.4] [Reference Citation Analysis]
2 Takeda A, Oku Y, Sanuki N, Kunieda E, Koike N, Aoki Y, Ohashi T, Iwabuchi S, Takatsuka K, Takeda T. Dose volume histogram analysis of focal liver reaction in follow-up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma. Radiother Oncol. 2012;104:374-378. [PMID: 22248506 DOI: 10.1016/j.radonc.2011.12.008] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
3 Kim EH, Kim MS, Furusawa Y, Uzawa A, Han S, Jung WG, Sai S. Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams. Oncotarget 2016;7:80568-78. [PMID: 27802188 DOI: 10.18632/oncotarget.12966] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
4 Polan DF, Feng M, Lawrence TS, Ten Haken RK, Brock KK. Implementing Radiation Dose-Volume Liver Response in Biomechanical Deformable Image Registration. Int J Radiat Oncol Biol Phys 2017;99:1004-12. [PMID: 28864401 DOI: 10.1016/j.ijrobp.2017.06.2455] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
5 Kanda T, Ogasawara S, Chiba T, Haga Y, Omata M, Yokosuka O. Current management of patients with hepatocellular carcinoma. World J Hepatol 2015; 7(15): 1913-1920 [PMID: 26244066 DOI: 10.4254/wjh.v7.i15.1913] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
6 Rim CH, Park S, Woo JY, Seong J. Compensatory hypertrophy of the liver after external beam radiotherapy for primary liver cancer. Strahlenther Onkol 2018;194:1017-29. [PMID: 30105451 DOI: 10.1007/s00066-018-1342-y] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Sanford NN, Pursley J, Noe B, Yeap BY, Goyal L, Clark JW, Allen JN, Blaszkowsky LS, Ryan DP, Ferrone CR, Tanabe KK, Qadan M, Crane CH, Koay EJ, Eyler C, DeLaney TF, Zhu AX, Wo JY, Grassberger C, Hong TS. Protons vs Photons for Unresectable Hepatocellular Carcinoma: Liver Decompensation and Overall Survival. Int J Radiat Oncol Biol Phys. 2019;105:64-72. [PMID: 30684667 DOI: 10.1016/j.ijrobp.2019.01.076] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 15.0] [Reference Citation Analysis]
8 Wang Z, Wang W, Shahnazi K, Jiang G. Carbon Ion Radiation Therapy for Liver Tumors. In: Lee NY, Leeman JE, Cahlon O, Sine K, Jiang G, Lu JJ, Both S, editors. Target Volume Delineation and Treatment Planning for Particle Therapy. Cham: Springer International Publishing; 2018. pp. 221-34. [DOI: 10.1007/978-3-319-42478-1_14] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
9 Kamada T. Clinical evidence of particle beam therapy (carbon). Int J Clin Oncol 2012;17:85-8. [DOI: 10.1007/s10147-012-0388-6] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
10 Yasuda S, Kato H, Imada H, Isozaki Y, Kasuya G, Makishima H, Tsuji H, Ebner DK, Yamada S, Kamada T, Tsujii H, Kato N, Miyazaki M; Working Group for Liver Tumor. Long-Term Results of High-Dose 2-Fraction Carbon Ion Radiation Therapy for Hepatocellular Carcinoma. Adv Radiat Oncol 2020;5:196-203. [PMID: 32280819 DOI: 10.1016/j.adro.2019.09.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
11 Ebara M, Shibuya K, Shimada H, Kawashima M, Hirasawa H, Taketomi-Takahashi A, Ohno T, Tsushima Y. Evaluation of Threshold Dose of Damaged Hepatic Tissue After Carbon-Ion Radiation Therapy Using Gd-EOB-DTPA-Enhanced Magnetic Resonance Imaging. Adv Radiat Oncol 2021;6:100775. [PMID: 34934860 DOI: 10.1016/j.adro.2021.100775] [Reference Citation Analysis]
12 Abousaida B, Seneviratne D, Hoppe BS, Ko SJ, Asaithamby A, Cucinotta FA, Kirwan JM, Mody K, Toskich B, Ashman JB, Hallemeier CL, Krishnan S. Carbon Ion Radiotherapy in the Management of Hepatocellular Carcinoma. J Hepatocell Carcinoma 2021;8:1169-79. [PMID: 34595139 DOI: 10.2147/JHC.S292516] [Reference Citation Analysis]
13 Yeh SA, Chen YS, Perng DS. The role of radiotherapy in the treatment of hepatocellular carcinoma with portal vein tumor thrombus. J Radiat Res 2015;56:325-31. [PMID: 25411553 DOI: 10.1093/jrr/rru104] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
14 Huang Y, Hidaka M, Takatsuki M, Soyama A, Adachi T, Ono S, Kugiyama T, Hara T, Okada S, Yoshimoto T, Hamada T, Eguchi S. Surgical findings and technical knacks to performing living donor liver transplantation for hepatocellular carcinoma recurrence after carbon ion radiotherapy. J Surg Case Rep 2018;2018:rjy228. [PMID: 30151117 DOI: 10.1093/jscr/rjy228] [Reference Citation Analysis]
15 Li Z, Li Q, Wang X, Li S, Chen W, Jin X, Liu X, Dai Z, Liu X, Zheng X, Li P, Zhang H, Zhang Q, Luo H, Liu R. Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis. Front Public Health 2021;9:767617. [PMID: 34957022 DOI: 10.3389/fpubh.2021.767617] [Reference Citation Analysis]
16 Takamatsu S, Yamamoto K, Maeda Y, Kawamura M, Shibata S, Sato Y, Terashima K, Shimizu Y, Tameshige Y, Sasaki M, Asahi S, Kondou T, Kobayashi S, Matsui O, Gabata T. Evaluation of Focal Liver Reaction after Proton Beam Therapy for Hepatocellular Carcinoma Examined Using Gd-EOB-DTPA Enhanced Hepatic Magnetic Resonance Imaging. PLoS One 2016;11:e0167155. [PMID: 27907063 DOI: 10.1371/journal.pone.0167155] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
17 Han S, Lee HW, Park JY, Kim SU, Kim DY, Ahn SH, Han KH, Seong J, Won JY, Han DH, Kim BK. Appraisal of Long-Term Outcomes of Liver-Directed Concurrent Chemoradiotherapy for Hepatocellular Carcinoma with Major Portal Vein Invasion. J Hepatocell Carcinoma 2020;7:403-12. [PMID: 33365287 DOI: 10.2147/JHC.S276528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yoshida M, Ogino H, Iwata H, Hattori Y, Hashimoto S, Nakajima K, Sasaki S, Hara M, Sekido Y, Mizoe JE, Shibamoto Y. Transient increases in serum α fetoprotein and protein induced by vitamin K antagonist II levels following proton therapy does not necessarily indicate progression of hepatocellular carcinoma. Oncol Lett 2019;17:3026-34. [PMID: 30854081 DOI: 10.3892/ol.2019.9922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Lee HS, Choi GH, Choi JS, Kim KS, Han K, Seong J, Ahn SH, Kim DY, Park JY, Kim SU, Kim BK. Surgical Resection After Down-Staging of Locally Advanced Hepatocellular Carcinoma by Localized Concurrent Chemoradiotherapy. Ann Surg Oncol 2014;21:3646-53. [DOI: 10.1245/s10434-014-3652-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 3.8] [Reference Citation Analysis]
20 Law AL, Ng W, Lee MC, Chan AT, Fung K, Li F, Lao W, Lee AW. Treatment of primary liver cancer using highly-conformal radiotherapy with kv-image guidance and respiratory control. Radiotherapy and Oncology 2012;102:56-61. [DOI: 10.1016/j.radonc.2011.05.022] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]